Dr. Srihari Konduri received his bachelor’s degree from Acharya Nagarjuna University, India, and his master’s from Andhra University, India. After that started his working career in the pharmaceutical industry and concurrently completed his Ph.D. from Vignan University (VFSTR), Guntur, India. He has 13 years of pharmaceutical experience and currently working as SRA III under Prof. Dionicio Siegel at the University of California San Diego (UCSD). The main focus of his current research is on identifying and synthesis of new drugs- like compounds for the treatment of diabetes, colitis, multiple sclerosis, and cancers.